Highlands Oncology Group, PA — Springdale, Arkansas

Highlands Oncology Group, PA is a clinical research site located in Springdale, Arkansas, United States 72762.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group, PA has participated in 11 clinical trials with 9 currently active.

Therapeutic areas: Advanced Malignancies, NSCLC, Ovarian Cancer.

Sponsors: Pfizer, Stemline Therapeutics, Inc., Shanghai Henlius Biotech.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group, PA?

Highlands Oncology Group, PA has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group, PA conducted?

Highlands Oncology Group, PA has 11 clinical trials on record, with 9 currently active. Their work covers Advanced Malignancies, NSCLC, Ovarian Cancer.

Is Highlands Oncology Group, PA accredited by Crixeo Health?

Yes — Highlands Oncology Group, PA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Highlands Oncology Group, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.